Latest Breaking News On - Ted karkus - Page 1 : comparemela.com
ProPhase Labs, Inc. (NASDAQ: PRPH) saw its shares lose some strength Wednesday, as the next-generation biotech, genomics, and diagnostics company, reported its progress on the commercialization of its breakthrough BE-Smart test for esophageal cancer. .
Ted-karkus
Prophase-labs-inc
Nasdaq
Prophase-lab
Prophase-labs